BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoberman A, Marchant CD, Kaplan SL, Feldman S. Treatment of Acute Otitis Media Consensus Recommendations. Clin Pediatr (Phila) 2002;41:373-90. [DOI: 10.1177/000992280204100602] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Jacobs MR, Johnson CE. Macrolide resistance: an increasing concern for treatment failure in children: . The Pediatric Infectious Disease Journal 2003;22:S131-8. [DOI: 10.1097/00006454-200308001-00004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
2 Perry CM, Scott LJ. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Drugs 2004;64:1433-64. [PMID: 15212560 DOI: 10.2165/00003495-200464130-00004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
3 Powers JH. Diagnosis and Treatment of Acute Otitis Media: Evaluating the Evidence. Infectious Disease Clinics of North America 2007;21:409-26. [DOI: 10.1016/j.idc.2007.03.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
4 Dubé E, De Wals P, Gilca V, Boulianne N, Ouakki M, Lavoie F, Bradet R. New vaccines offering a larger spectrum of protection against acute otitis media: Will parents be willing to have their children immunized? International Journal of Pediatric Otorhinolaryngology 2009;73:987-91. [DOI: 10.1016/j.ijporl.2009.03.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
5 McCormick DP, Chandler SM, Chonmaitree T. Laterality of acute otitis media: different clinical and microbiologic characteristics. Pediatr Infect Dis J 2007;26:583-8. [PMID: 17596798 DOI: 10.1097/INF.0b013e31803dd380] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Wals PD, Carbon M, Sévin E, Deceuninck G, Ouakki M. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 2009;28:e271-5. [PMID: 19710582 DOI: 10.1097/INF.0b013e3181bad212] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
7 Canut A, Martin-Herrero JE, Maortua H, Labora A, Isla A, Rodriguez-Gascon A. Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: a therapeutic outcomes model. J Chemother 2009;21:408-13. [PMID: 19622459 DOI: 10.1179/joc.2009.21.4.408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Andrews TM. Current concepts in antibiotic resistance: . Current Opinion in Otolaryngology & Head and Neck Surgery 2003;11:409-15. [DOI: 10.1097/00020840-200312000-00001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Coticchia JM, Chen M, Sachdeva L, Mutchnick S. New paradigms in the pathogenesis of otitis media in children. Front Pediatr 2013;1:52. [PMID: 24400296 DOI: 10.3389/fped.2013.00052] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
10 Felmingham D, Farrell DJ, Reinert RR, Morrissey I. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000). J Infect 2004;48:39-55. [PMID: 14667791 DOI: 10.1016/s0163-4453(03)00140-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
11 Rubino CM, Bradley JS. Optimizing Therapy with Antibacterial Agents: Use of Pharmacokinetic-Pharmacodynamic Principles in Pediatrics. Pediatric Drugs 2007;9:361-9. [DOI: 10.2165/00148581-200709060-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Skinner LJ, Beurg M, Mitchell TJ, Darrouzet V, Aran J, Dulon D. Intracochlear Perfusion of Pneumolysin, a Pneumococcal Protein, Rapidly Abolishes Auditory Potentials in the Guinea Pig Cochlea. Acta Oto-Laryngologica 2009;124:1000-7. [DOI: 10.1080/00016480410017125] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Forgie S, Zhanel G, Robinson J; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Management of acute otitis media. Paediatrics & Child Health 2009;14:457-60. [DOI: 10.1093/pch/14.7.457] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
14 Arrieta A, Singh J. Management of recurrent and persistent acute otitis media: new options with familiar antibiotics. Pediatr Infect Dis J 2004;23:S115-24. [PMID: 14770074 DOI: 10.1097/01.inf.0000112525.88779.8b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
15 Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Ann Clin Microbiol Antimicrob 2008;7:1. [PMID: 18190701 DOI: 10.1186/1476-0711-7-1] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 6.6] [Reference Citation Analysis]
16 Sher L, Arguedas A, Husseman M, Pichichero M, Hamed KA, Biswas D, Pierce P, Echols R. Randomized, Investigator-Blinded, Multicenter, Comparative Study of Gatifloxacin Versus Amoxicillin/Clavulanate in Recurrent Otitis Media and Acute Otitis Media Treatment Failure in Children. Pediatric Infectious Disease Journal 2005;24:301-8. [DOI: 10.1097/01.inf.0000157084.35865.ba] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
17 Jahn-Eimermacher A, du Prel JB, Schmitt HJ. Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials. Vaccine 2007;25:6237-44. [PMID: 17629378 DOI: 10.1016/j.vaccine.2007.05.062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
18 Ren D, Walker AN, Daines DA. Toxin-antitoxin loci vapBC-1 and vapXD contribute to survival and virulence in nontypeable Haemophilus influenzae. BMC Microbiol 2012;12:263. [PMID: 23157645 DOI: 10.1186/1471-2180-12-263] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
19 Courter JD, Baker WL, Nowak KS, Smogowicz LA, Desjardins LL, Coleman CI, Girotto JE. Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis. Ann Pharmacother 2010;44:471-8. [PMID: 20150506 DOI: 10.1345/aph.1M344] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
20 Low DE, Pichichero ME, Schaad UB. Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance. Clin Pediatr (Phila) 2004;43:135-51. [PMID: 15024437 DOI: 10.1177/000992280404300203] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
21 Leibovitz E, Broides A, Greenberg D, Newman N. Current management of pediatric acute otitis media. Expert Review of Anti-infective Therapy 2014;8:151-61. [DOI: 10.1586/eri.09.112] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
22 Phipps KR. No evidence to support the claim that amoxicillin causes molar-incisor hypomineralization. J Evid Based Dent Pract 2010;10:112-4. [PMID: 20466325 DOI: 10.1016/j.jebdp.2010.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Pichichero ME, Casey JR. Diagnostic inaccuracy and subject exclusions render placebo and observational studies of acute otitis media inconclusive. Pediatr Infect Dis J 2008;27:958-62. [PMID: 18845985 DOI: 10.1097/INF.0b013e318179a2ac] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J Antimicrob Chemother. 2007;60:323-327. [PMID: 17562681 DOI: 10.1093/jac/dkm209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
25 Appelbaum PC. Are Cephalosporins Appropriate for the Treatment of Acute Otitis Media in This Era of Increasing Antimicrobial Resistance Among Common Respiratory Tract Pathogens? Clin Pediatr (Phila) 2005;44:95-107. [DOI: 10.1177/000992280504400201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Greenberg D, Hoffman S, Leibovitz E, Dagan R. Acute Otitis Media in Children: Association with Day Care Centers ??? Antibacterial Resistance, Treatment, and Prevention. Pediatric Drugs 2008;10:75-83. [DOI: 10.2165/00148581-200810020-00002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
27 Segal N, Leibovitz E, Dagan R, Leiberman A. Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines. Int J Pediatr Otorhinolaryngol 2005;69:1311-9. [PMID: 15955573 DOI: 10.1016/j.ijporl.2005.05.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
28 Bousquet J, Fiocchi A. Prevention of Recurrent Respiratory Tract Infections in Children Using a Ribosomal Immunotherapeutic Agent: A Clinical Review. Pediatric Drugs 2006;8:235-43. [DOI: 10.2165/00148581-200608040-00003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
29 Chandler SM, Garcia SM, McCormick DP. Consistency of diagnostic criteria for acute otitis media: a review of the recent literature. Clin Pediatr (Phila) 2007;46:99-108. [PMID: 17325082 DOI: 10.1177/0009922806297163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
30 Murphy TF. Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 2003;16:129-34. [PMID: 12734445 DOI: 10.1097/00001432-200304000-00009] [Cited by in Crossref: 112] [Cited by in F6Publishing: 117] [Article Influence: 5.9] [Reference Citation Analysis]
31 Hays JP. The Genus Moraxella. In: Dworkin M, Falkow S, Rosenberg E, Schleifer K, Stackebrandt E, editors. The Prokaryotes. New York: Springer; 2006. pp. 958-87. [DOI: 10.1007/0-387-30746-x_38] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
32 Phipps KR. No evidence to support the claim that amoxicillin causes molar-incisor hypomineralization. J Evid Based Dent Pract 2012;12:73-5. [PMID: 23253836 DOI: 10.1016/S1532-3382(12)70018-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Dhaon NA. Amoxicillin tablets for oral suspension in the treatment of acute otitis media: a new formulation with improved convenience. Adv Ther 2004;21:87-95. [PMID: 15310082 DOI: 10.1007/BF02850336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Farrell DJ, Jenkins SG, Brown SD, Patel M, Lavin BS, Klugman KP. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis 2005;11:851-8. [PMID: 15963279 DOI: 10.3201/eid1106.050222] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
35 De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine 2009;27:2877-83. [DOI: 10.1016/j.vaccine.2009.02.102] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
36 Arrieta A, Arguedas A, Fernandez P, Block SL, Emperanza P, Vargas SL, Erhardt WA, de Caprariis PJ, Rothermel CD. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother 2003;47:3179-86. [PMID: 14506028 DOI: 10.1128/AAC.47.10.3179-3186.2003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
37 Montgomery D. A new approach to treating acute otitis media. J Pediatr Health Care 2005;19:50-2. [PMID: 15662363 DOI: 10.1016/j.pedhc.2004.10.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Hoberman A, Dagan R, Leibovitz E, Rosenblut A, Johnson CE, Huff A, Bandekar R, Wynne B. Large Dosage Amoxicillin/Clavulanate, Compared With Azithromycin, for the Treatment of Bacterial Acute Otitis Media in Children. Pediatric Infectious Disease Journal 2005;24:525-32. [DOI: 10.1097/01.inf.0000164794.50281.1a] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]